Unaudited Condensed Consolidated Statements of Stockholders’ Equity - USD ($)	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Balance at Dec. 31, 2020	$ 22,535	$ 71,648,453	$ (51,538)	$ (34,279,648)	$ 37,339,802
Balance (in Shares) at Dec. 31, 2020	22,534,874
Sale of common stock, net of offering costs	$ 2,140	28,021,424			28,023,564
Sale of common stock, net of offering costs (in Shares)	2,140,000
Issuance of common stock for stock option exercises	$ 245	655,008			655,253
Issuance of common stock for stock option exercises (in Shares)	244,656
Issuance of common stock for warrant exercises	$ 444	179,768			180,212
Issuance of common stock for warrant exercises (in Shares)	444,751
Stock-based compensation		1,030,415			1,030,415
Foreign currency translation adjustment			(37,958)		(37,958)
Net loss				(7,654,575)	(7,654,575)
Balance at Mar. 31, 2021	$ 25,364	101,535,068	(89,496)	(41,934,223)	59,536,713
Balance (in Shares) at Mar. 31, 2021	25,364,281
Balance at Dec. 31, 2021	$ 25,372	104,078,968	(48,921)	(65,318,360)	38,737,059
Balance (in Shares) at Dec. 31, 2021	25,371,781
Stock-based compensation		1,177,702			1,177,702
Foreign currency translation adjustment			47,234		47,234
Net loss				(8,376,002)	(8,376,002)
Balance at Mar. 31, 2022	$ 25,372	$ 105,256,670	$ (1,687)	$ (73,694,362)	$ 31,585,993
Balance (in Shares) at Mar. 31, 2022	25,371,781